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Background
With the genome of Plasmodium vivax sequenced [1], it
would be important to determine proteomes of the
parasite in order to assist efforts in understanding the
basic biology of the parasite as well as provides the new
tools for identifying novel antigens and drug targets.
Materials and methods
Lysates of P. vivax were separated by SDS-polycryla-
mide gel electrophoresis (SDS-PAGE) and proteins were
identified by using matrix-assisted laser desorption/ioni-
zation-time of flight (MALDI-TOF/TOF) mass spectro-
metry. In addition, to identify proteins that might be
1Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand
Full list of author information is available at the end of the article
Table 1 Functional classes of all identified proteins.
Functional classes %
Cellular transport 4.0
Hypothetical 48.0
Metabolism 4.0
Protein fate 5.0
Protein synthesis 4.0
Protein with binding function 10.0
Unclassified 18.0
Others 7.0
Figure 1 Plasmodium vivax proteins recognized by immune serum (a), and antibody responses to PV180L protein in convalescence sera (dash
line indicate ELISA cut-off value).
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rated them by two-dimensional gel electrophoresis. Pro-
teins were then screened by western blot with immune
serum. Spots that were recognized by the host serum
were excised and identified by high-accuracy liquid
chromatography-tandem mass spectrometry (LC-MS/
MS).
Results
Several hundred proteins were confidently identified. All
proteins were classified into functional classes (see
Table 1). Four parasite proteins were recognized by P.
vivax-immune human sera. Interestingly, one of the four
proteins (PV180L), reacted with the convalescence sera,
6 months post treatment of P. vivax-immune donors
(see Figure 1).
Conclusion
The PV180L encodes a 24.1 kDa hypothetical protein
which expressed throughout the erythrocytic cycle of P.
vivax and the antibodies to PV180L were long lasting.
Therefore, more reports on the proteins of P. vivax
parasite provide useful information and availability to
facilitate not only basic research on this extraordinary
malaria parasite, but also provide the new tools for drug
and vaccine developments.
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